Cooperative Agreement 72067424CA00001

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), supports the South Carolina Department of Public Health (SCDPH) in implementing comprehensive efforts to prevent, diagnose, and manage HIV across South Carolina. The $1,201,336 award, effective January 1, 2025 through December 31, 2029, will fund SCDPH's activities focused on: (1) identifying and treating...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a $766,877 randomized controlled trial to evaluate the efficacy of therapeutic drug monitoring (TDM) for linezolid in the treatment of rifampin-resistant tuberculosis (RR-TB). The primary objective is to determine if TDM can prevent premature discontinuation of linezolid, a critical drug for treating RR-TB. The...

The federal Cooperative Agreement award, with a total funding amount of $3,347,959.00, was granted by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award, titled "ACHIEVING AND SUSTAINING HIV/TB EPIDEMIC CONTROL IN THE FREE STATE PROVINCE", aims to support HIV/TB epidemic control efforts in South Africa's Free State Province. The prime awardee, Right To Care, is a non-profit healthcare...

This $960,090 Cooperative Agreement award, funded by the National Center for HIV/AIDS and titled "HIV Prevention Activities Health Department Based" (CFDA 93.940), supports the Arkansas Department of Health (ADH) in implementing comprehensive HIV prevention and surveillance strategies across the state. The key products and services to be delivered under this 5-year award (2025-2029) include: (1) rapid diagnosis and treatment of tuberculosis (TB) disease, (2) enhanced detection and...

This Cooperative Agreement award from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $7,950,000 to the South African National AIDS Council Trust (SANAC Trust) to support comprehensive efforts to combat HIV/AIDS in South Africa. The funding will be used to assist SANAC Trust in the multi-sectoral coordination, management, monitoring, and community engagement activities related to the country's...

This Cooperative Agreement award of $4,968,390 from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports the South African Medical Research Council (MRC) in strengthening strategic health information systems to combat HIV/AIDS in South Africa and the broader sub-Saharan African region. The 5-year award, effective September 30, 2024, will enable MRC to provide technical assistance, build capacity, and deliver direct services across the HIV...

The Centers for Disease Control and Prevention (CDC) awarded a $1,120,840 Cooperative Agreement (CFDA 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs) to the Alabama Department of Public Health (ADPH) to conduct comprehensive tuberculosis (TB) prevention, control, and elimination activities within the state of Alabama. The funding will support critical public health services including TB surveillance, diagnosis, treatment, contact investigations, targeted...

This Project Grant award of $1,011,348 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how interactions between Mycobacterium tuberculosis (M.TB) and the human alveolar environment, particularly in people living with HIV, impact the early stages of TB infection. The key objectives are to: 1) Determine how M.TB exposure to alveolar lining fluid from people living with...

The South Dakota Department of Health (SD DOH) has been awarded a $319,619 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The purpose of this 5-year award, effective January 1, 2025, is to assist SD DOH in preventing tuberculosis (TB) transmission and reducing the TB case rate in South Dakota. Key activities funded include supporting 1 FTE TB Program Manager, 0.5...

The Defense Health Agency awarded a $215,429 Project Grant to The Global Alliance For TB Drug Development Inc. (TB Alliance) to investigate a host-directed proteolysis-targeting chimera (PROTAC) approach for targeting intracellular Mycobacterium tuberculosis. This two-year grant, running from July 2024 to July 2026, supports TB Alliance's research and development efforts to accelerate the development of new tuberculosis (TB) drugs and treatment regimens. The funding falls under the Military...